Chapter PDF
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Abu-Salah, K. M., 1996, Amphotericin B: An update Br. J. Biomed. Sci. 53:122–133.
Adler, H., Beland, J. L., Del-Pan, N. C., Kobzik, L.. Brewer, J. P., Martin, T. R., and Rimm, I. J., 1997, Suppression of herpes simplex virus type 1 (HSV-1 )-induced pneumonia in mice by inhibition of inducible nitric oxide synthase (iNOS, NOS2), J. Exp. Med. 185:1533–1540.
Aeberhard, E. E., Henderson, S. A., Arabolos, N. S., Griscavage, J. M., Castro, F. E., Barrett, C. T., and Ignarro, L. J., 1995, Nonsteroidal anti-inflammatory drugs inhibit expression of the inducible nitric oxide synthase gene, Biochem. Biophys. Res. Commun. 208:1053–1059.
Akaike, T., Noguchi, Y., Ijiri, S., Setoguchi, K., Suga, M., Zheng, Y. M., Dietzschold, B., and Maeda, H., 1996, Pathogenesis of influenza virus-induced pneumonia: Involvement of both nitric oxide and oxygen radicals, Proc. Natl. Acad. Sci. USA 93:2448–2453.
Amin, A. R., Vyas, P., Attur, M., Leszczynska-Piziak, J., Patel, I. R., Weissmann, G., and Abramson, S. B., 1995, The mode of action of aspirin-like drugs: Effect on inducible nitric oxide synthase, Proc. Natl. Acad. Sci. USA 92:7926–7930.
Amin, A. R., Attur, M. G., Thakker, G. D., Patel, P. D., Vyas, P. R., Patel, R. N., Patel, I. R., and Abramson, S. B., 1996, A novel mechanism of action of tetracyclines: Effects on nitric oxide synthases, Proc. Natl. Acad. Sci. USA 93:14014–14019.
Ash, C., 1996, Antibiotic resistance: The new apocalypse? Trends Micribiol. 4:371–372.
Austin, O. M. B., Redmond, H. P., Watson, R. W. G., Cunney, R. J., Grace, P. A., and Boudhier-Hayes, D., 1995, The beneficial effects of immunostimulation in posttraumatic sepsis, J. Surg. Res. 59:446–449.
Barbul, A., Wasserkrug, H. L., Seifter, E., Rettura, G., Levenson, S. M., and Efron, G., 1980, Immunostimulatory effects of arginine in normal and injured rats, J. Surg. Res. 29:228–235.
Bartsch, H., Ohshima, H., Pignatelli, B., and Calmels, S., 1992, Endogenously formed N-nitroso compounds and nitrosating agents in human cancer etiology, Pharmacogenetics 2:272–277.
Berrazueta, J. R., Fleitas, M., Salas, E., Amado, J. A., Poveda, J., Ochoteco, A., Sanchez de Vega, M. J., and Ruiz de Celis, G., 1994, Local transdermal glyceryl trinitrate has an antiinflammatory action on thrombophlebitis induced by sclerosis of leg varicose veins, Angiology 45:347–351.
Chan, J., Tian, Y, Tanaka, K. E., Tsang, M. S., Yu, K., Salgame, P., Carroll, D., Kress, Y, Teitelbaum, R., and Bloom, B. R., 1996, Effects of protein calorie malnutrition on tuberculosis in mice, Proc. Natl. Acad. Sci. USA 93:14857–14861.
Chodosh, J., Holder, V. P., Gan, Y. J., Belgaumi, A., Sample, J., and Sixbey, J. W., 1998, Eradication of latent Epstein-Barr virus by hydroxyurea alters the growth-transformed cell phenotype, J. Infect. Dis. 177:1194–1201.
Conde, M., Andrade, J., Bedoya, F. J., Santa Maria, C., and Sobrino, F., 1995, Inhibitory effect of cyclosporin A and FK506 on nitric oxide production by cultured macrophages. Evidence of a direct effect on nitric oxide synthase activity, Immunology 84:476–481.
Crane, B. R., Arvai, A. S., Gachhui, R., Wu, C., Ghosh, D. K., Getzoff, E. D., Stuehr, D. J., and Tainer, J. A., 1997, The structure of nitric oxide synthase oxygenase domain and inhibitor complexes, Science 278:425–31.
Croen, K. D., 1993, Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication, J. din. Invest. 91:2446–2452.
De Angelo, J., 1997, PHP in the treatment of nitric oxide dependent shock, in: Nitric Oxide: Novel Therapeutics for Clinical Application, International Business Communications, Philadelphia.
De Koster, E., Buset, M., Fernandes, E., and Deltenre, M., 1994, Helicobacter pylori: The link with gastric cancer, Eur. J. Cancer Prevent. 3:247–257.
Dinarello, C., 1995, Cytokines as mediators in the pathogenesis of septic shock, Curr. Top. Microbiol. Immunol. 196:133–165.
DiRosa, M., Radomski, M., Carnuccio, R., and Moncada, S., 1990, Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages, Biochem. Biophys. Res. Commun. 172:1246–1252.
Evans, T. J., and Cohen, T., 1995, Nitric oxide and other toxic oxygen species, Curr. Top. Microbiol. Immunol. 216:189–207.
Flak, T. A., and Goldman, E., 1996, Autotoxicity of nitric oxide in airway disease, Am. J. Respir. Crit. Care Med. 154:S202–S206.
Fox, J. G., 1994, Gastric disease in ferrets: Effects of Helicobacter mustelae, nitrosamines and reconstructive gastric surgery, Eur. J. Gastroenterol. Hepatol. 6(Suppl 1):S57–S65.
Gennari, R., and Alexander, J. W, 1997, Arginine, glutamine, and dehydroepiandrosterone reverse the immunosuppressive effect of prednisone during gut-derived sepsis, Crit. Care Med. 25:1207–1214.
Gianatti, L., Alexander, J. W., Pyles, T., and Fukushima, R., 1993, Arginine-supplemented diets improve survival in gut-derived sepsis and peritonitis by modulating bacterial clearance, Ann. Surg. 217:644–654.
Gold, H. S., and Moellering, R. C., Jr., 1996, Antimicrobial-drug resistance, N. Engl. J. Med. 335:1445–1453.
Gomez-Jimenez, J., Salgado, A., Mourelle, M., Martin, M. C., Segura, R. M., Peracaula, R., and Moncada, S., 1995, l-Arginine: Nitric oxide pathway in endotoxemia and human septic shock, Crit. Care Med. 23:253–258.
Gow, A. J., and Stamler, J. S., 1998, Reaction between nitric oxide and haemoglobin under physiological conditions, Nature 391:169–173.
Heiss, L. N., Lancaster, J. R., Jr., Corbett, J. A., and Goldman, W. E., 1994, Epithelial autotoxicity of nitric oxide: Role in the respiratory cytopathology of pertussis, Proc. Natl. Acad. Sci. USA 91:267–270.
Heneka, M. T., Loschmann, P. A., and Osswald, H., 1997, Polymerized hemoglobin restores cardiovascular and kidney function in endotoxin-induced shock in the rat, J.Clin. Invest 99:47–54.
Hill, A. D., Naama, H., Shou, J., Calvano, S. E., and Daly, J. M., 1995, Antimicrobial effects of granulocyte-macrophage colony-stimulating factor in protein-energy malnutrition, Arch. Surg. 130:1273–1277.
Horton, J. W., White, J., Maass, D., and Sanders, B., 1998, Arginine in burn injury improves cardiac performance and prevents bacterial translocation, J. Appl. Physiol. 84:695–702.
James, S. L., 1995, Role of nitric oxide in parasitic infections, Microbiol. Rev. 59:533–547.
Jourdain, M., Tounoys, A., Leroy, X., Mangalaboyi, J., Fourrier, F., Goudemand, J., Gosselin, B., Vallet, B., and Chopin, C., 1997, Effects of N G-nitro-l-arginine methyl ester on the endotoxin-induced disseminated intravascular coagulation in porcine septic shock, Crit. Care Med. 25:452–459.
Kane, J. M., Shears, L L., Hierholzer, C., Ambs, S., Billiar, T. R., and Posner, M. C., 1997, Chronic hepatitis C virus infection in humans: Induction of hepatic nitric oxide synthase and proposed mechanisms for carcinogenesis, J. Surg. Res. 69:321–324.
Karamanoukian, J. L., Glick, P. L., Zayek, M., Steinharn, R. M., Zwass, J. S., Fineman, J. R., and Morin, F. C. R., 1994, Inhaled nitric oxide in congenital hypoplasia of the lungs due to diaphragmatic hernia or oligohydramnios, Pediatrics 94:715–718.
Karupiah, G., Xie, Q. W., Buller, R. M., Nathan, C., Duarte, C., and MacMicking, J. D., 1993, Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase, Science 261:1445–1448.
Kawakami, K., Tohyama, M., Qifeng, X., and Saito, A., 1997, Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus nenfarmans: Effects of interleukin-12, Infect. Immun. 65:1307–1312.
Kazmierski, W. M., Wolberg, G., Wilson, J. G., Smith, S. R., Williams, D. S., Thorp, H. H., and Molina, L., 1996, Iron chelates bind nitric oxide and decrease mortality in an experimental model of septic shock, Proc. Natl. Acad. Sci. USA 93:9138–9141.
Khan, I. A., Schwartzman, J. D., Matsuura, T., and Kasper, L. H., 1997, A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice, Proc. Natl. Acad. Sci. USA 94:13955–13960.
Kilbourn, R.G., 1997, Nitric oxide overproduction in septic shock—Methemoglobin concent rations and blockade with diaspirin cross-linked hemoglobin, Crit. Care Med. 25:1446–1447.
Kilbourn, R. G., Jubran, A., Gross, S. S., Griffith, O. W., Levi, R., Adams, J., and Lodato, R. F., 1990, Reversal of endotoxin-mediated shock by N-methyl-l-argininc, an inhibitor of nitric oxide synthesis, Biochem. Biophys. Res. Commun. 172:1132–1138.
Kilbourn, R. G., Szabo, C., and Traber, D. L., 1997a, Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: Lessons learned from experimental and clinical studies, Shock 7:235–246.
Kilbourn, R., Traber, D., and Szabo, C., 1997b, Nitric oxide and shock, Dis. Mon. 43:279–348.
Kimura, T., Nakayama, K., Penninger, J., Kitagawa, M., Harada, H., Matsuyama, T., Tanaka, N., Kamijo, R., Vilcek, J., Mak, T. W.,and Taniguchi, T., 1994, Involvement of the IRF-1 transcription factor in antiviral responses to interferons, Science 264:1921–1924.
Kirk, S. J., Regan, N. C., Wasserkrug, H. L., Sodeyama, M., and Barbul, A., 1992, Arginine enhances T cell responses in athymic nude mice, J. Parenter. Enterol. Nutr. 16:429–432.
Komatsu, T., Bi, Z., and Reiss, C. S., 1996, Interferon-gamma induced type I nitric oxide synthase activity inhibits viral replication in neurons, J. Neuroimmunol 68:101–108.
Krafft, P., Fridich, P., Fitzgerald, R. D., Koc, D., and Steltzer, H., 1996, Effectiveness of nitric oxide inhalation in septic ARDS, Chest 109:486–493.
Kwon, N. S., Stuehr, D. J., and Nathan, C. F, 1991, Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide, J. Exp. Med. 174:761–767.
Langford, E. J., Brown, A. S., Wainwright, R. J., de Belder, A. J., Thomas, M. R., Smith, R. E., Radomski, M. W., Martin, J. F, and Moncada, S., 1994, Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty, Lancet 344:1458–1460.
Liaudet, L., Rosselet, A., Schaller, M. D., Markert, M., Perret, C., and Feihl, F., 1998, Nonselective versus selective inhibition of inducible nitric oxide synthase in experimental endotoxic shock, J. Infect. Dis. 177:127–132.
Lopez-Jaramillo, P., Ruano, C., Rivera, J., Teran, L., and Moncada, S., 1995, Treatment of cutaneous mycosis with the NO donor S-nitroso-N-acetylpenicillamine (SNAP), Endothelium 3(Suppl. 1 ):s 13.
Lopez-Jaramillo, P., Ruano, C., Rivera, J., Teran, E., Salazar-Irigoyen, R., Esplugues, J. V, and Moncada, S., 1998, Treatment of cutaneous leishmaniasis with nitric-oxide donor, Lancet 351:1176–1177.
Lori, F, Malykh, A., Cara, A., Sun, D., Weinstein, J. N., Lisziewicz, J., and Gallo, R. C., 1994, Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication, Science 266:801–805.
Louie, A., Baltch, A. L., Franke, M. A., Smith, R. P., and Gordon, M. A., 1994, Comparative capacity of four antifungal agents to stimulate murine macrophages to produce tumour necrosis factor-alpha: An effect that is attenuated by pentoxifylline, liposomal vesicles and dexamethasone, J. Antimicrob. Chemother. 34:975–987.
Lovchik, J. A., Lyons, C. R., and Lipscomb, M. F, 1995, A role for gamma interferon-induced nitric oxide in pulmonary clearance of Cryptococcus neoformans, Am. J. Respir. Cell. Mol. Biol. 13:116–124.
MacMicking, J., Xie, Q. W., and Nathan, C., 1997a, Nitric oxide and macrophage function, Annu. Rev. Immunol. 15:323–350.
MacMicking, J. D., North, R. J., LaCouse, R., Mudgett, J. S., Shah, S. K., and Nathan, C. F, 1997b, Identification of nitric oxide synthase as a protective locus against tuberculosis, Proc. Natl. Acad. Sci. USA 94:5243–5248.
Maeda, H., Akaike, T., Yoshida, M., Sato, K., and Noguchi, Y., 1995, A new nitric oxide scavenger, imidazolineoxyl N-oxide derivative, and its effects in pathophysiology and microbiology, Curr. Top. Microbiol. Immunol. 196:37–50.
Mannick, E. E,., Bravo, L. E., Zarama, G., Realpe, J. L., Zhang, X. J., Ruiz, B., Fonham, E. T., Mera, R., Miller, M. J., and Correa, P., 1996, Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: Effect of antibiotics and antioxidants, Cancer Res. 56:3238–3243.
McElhaney-Feser, G. E., Raulli, R. E., and Cihlar, R. L., 1998, Synergy of nitric oxide releasing compounds and azoles against Candida species in vitro, Antimicrob. Agents Chemother. 42:2342–2346.
Meyding-Lamade, U., Haas, J, Lamade, W., Stingele, K., Kehm, R., Fath, A., Heinrich, K., Hagenlocher, B. S., and Wildemann, B., 1998, Herpes simplex virus encephalitis—Long-term comparative study of viral load and the expression of immunologic nitric oxide synthase in mouse brain tissue, Neurosci. Lett. 244:9–12.
Milano, S., Arcoleo, F, D’Agostino, P., and Cillari, E., 1997, Intraperitoneal injection of tetracyclines protects mice from lethal endotoxemia downregulating inducible nitric oxide synthase in various organs and cytokine and nitrate secretion in blood, Antimicrob. Agents Chemother. 41:117–121.
Mitaka, C., Hirata, Y., Ichikawa, K., Uchida, T., Yokoyama, K., Nagura, T., Tsunoda, Y., and Amaha, K.., 1995, Effects of nitric oxide synthase inhibitor on hemodynamic change and O2 delivery in septic dogs, Am. J. Physiol. 268:H2017–H2023.
Nathan, C., 1995, Natural resistance and nitric oxide, Cell 82:873–876.
Neu, H. C., 1992, The crisis in antibiotic resistance, Science 257:64–73.
Nicholson, S., Bonecini-Almeida, M. G., Lapa e Silva, J. R., Nathan, C., Xie, Q. W., Mumford, R., Weidner, J. R., Calaycay, J., Geng, J., Boechat, N., Linhares, C., Rom, W., and Ho, J. L., 1996, Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis, J. Exp. Med. 183:2293–2302.
Nicolle, L. E., Strausbaugh, L. J., and Garibaldi, R. A., 1996, Infections and antibiotic resistance in nursing homes, Clin. Microbiol. Rev. 9:1–17.
Ohshima, H., and Bartsch, H., 1994, Chronic infections and inflammatory processes as cancer risk factors: Possible role of nitric oxide in carcinogenesis, Mutat. Res. 305:253–264.
Pacelli, R., Taira, J., Cook, J. A., Wink, D. A., and Krishna, M. C., 1996, Hydroxyurea reacts with heme proteins to generate nitric oxide, Lancet 347:900.
Palmer, R. M. J., 1993, The discovery of nitric oxide in the vessel wall: A unifying concept in the pathogenesis of sepsis, Arch. Surg. 128:396–401.
Park, J. H., Chang, S. H., Lee, K. M., and Shin, S. H., 1996, Protective effect of nitric oxide in an endotoxin-induced septic shock, Am. J. Surg. 171:340–345.
Pedrinelli, R., Ebel, M., Catapano, G., Dell’Omo, G., Ducci, M., Del Chicca, M., and Clevico, A., 1995, Pressor, renal and endocrine effects of l-arginine in essential hypertensives, Eur. J. Clin. Pharmacol. 48:195–201.
Petros, A., Bennet, D., and Vallance, P., 1991, Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock, Lancet 338:1557–1558.
Petros, A., Lamb, G., Leone, A., Moncada, S., Bennett, D., and Vallance, P., 1994, Effects of a nitric oxide synthase inhibitor in humans with septic shock, Cardiovasc. Res. 28:34–39.
Reah, G., Bodenham, A. R., Mallick, A., Daily, E. K., and Przybelski, R. J., 1997, Initial evaluation of diasprin cross-linked hemoglobin (DCLHb) as a vasopressor in critically ill patients, Crit. Care Med. 25:1480–1488.
Rossero, R., McKinsey, D., Green, S., Andron, L., and Pollard, R., 1997, Open label combination therapy with stavudine, didanosine, and hydroxyurea in nucleoside experienced HIV-1 infected patients, in: Abstracts of the 5th Conference on Retroviruses and Opportunistic Infections, Chicago, #519.
Saavedra, J. E., Billiar, T. R., Williams, D. L., Kim, Y. M., Watkins, S. C, and Keefer, L. K., 1997, Targeting nitric oxide (NO) in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-alpha-induced apoptosis and toxicity in the liver, J. Med. Chem. 40:1947–1954.
Satarug, S., Haswell-Elkins, M., Tsuda, M., Mairiang, P., Sithithaworn, P., Mairiang, E., Esumi, H., Sukpraser, S., Yongvanit, P, and Elkins, D. B., 1996, Thiocyanate-independent nitrosation in humans with carcinogenic parasite infection, Carcinogenesis 17:1075–1081.
Sharara, A. I., Perkins, D. J., Misukonis, M. A., Chan, S. U, Dominitz, J. A., and Weinberg, J. B., 1997, Interferon (IFN)-α activation of human blood mononuclear cells in vitro and in vivo for nitric oxide synthase (NOS) type 2 mRNA and protein expression: Possible relationship of induced NOS2 to the anti-hepatitis C effects of IFN-α in vivo, J. Exp. Med. 186:1495–1502.
Su, D., Roth, R. I., Yoshida, M., and Levin, J., 1997, Hemoglobin increases mortality from bacterial endotoxin, Infect. Immun. 65:1258–1266.
Szabo, C., Southan, G. J., and Thiemermann, C., 1994, Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase, Proc. Natl. Acad. Sci. USA 91:12472–12476.
Tanaka, K., Nakazawa, H., Okada, K., Umezawa, K., Fukuyama, N., and Koga, Y., 1997, Nitric oxide mediates murine cytomegalovirus-associated pneumonitis in lungs that are free of the virus, J. Clin. Invest. 100:1822–1830.
Taylor, A. P., and Murray, H. W., 1997, Intracellular antimicrobial activity in the absence of interferon-gamma: Effect of interleukin-12 in experimental visceral leishmaniasis in interferon-gamma gene-disrupted mice, J. Exp. Med. 185:1231–1239.
Teale, D. M., and Atkinson, A. M., 1992, Inhibition of nitric oxide synthase improves survival in a murine peritonitis model of sepsis that is not cured by antibiotics alone, J. Antimicrob. Chemother. 30:839–842.
Teale, D. M., and Atkinson, A. M., 1994, L-Canavanine restores blood pressure in a rat model of endotoxic shock, Eur. J. Pharmacol. 271:87–92.
Thiemermann, C., 1994, Role of the L-arginine-nitric oxide pathway in circulatory shock, Adv. Pharmacol. 28:45–79.
Tohyama, M., Kawakami, K., and Saito, A., 1996, Anticryptococcal effect of amphotericin B is mediated through macrophage production of nitric oxide, Antimicrob. Agents Chemother. 40:1919–1923.
Tsuji, S., Kawano, S., Tsujii, M., Takei, Y, Tanaka, M., Sawaoka, H., Nagano, K., Fusamoto, H., and Kamada, T, 1996, Helicobacter pylori extract stimulates inflammatory nitric oxide production, Cancer Lett. 108:195–200.
Walker, G., Pfeilschifter, J., and Kunz, D., 1997, Mechanisms of suppression of inducible nitric-oxide synthase (iNOS) expression in interferon (IFN)-gamma-stimulated RAW 264.7 cells by dexamethasone. Evidence for glucocorticoid-induced degradation of iNOS protein by calpain as a key step in post-transcriptional regulation, J. Biol. Chem. 272:16679–16687.
Warren, W., Biggs, P. J., el-Baz, M., Ghoneim, M. A., Stratton, M. R., and Venitt, S., 1995, Mutations in the p53 gene in schistosomal bladder cancer: A study of 92 tumours from Egyptian patients and a comparison between mutational spectra from schistosomal and nonschistosomal urothelial tumours, Carcinogenesis 16:1181–1189.
Wegner, H. E., and Knispel, H. H., 1995, Effect of nitric oxide donor, linsidomine chlorhydrate, in treatment of human erectile dysfunction caused by venous leakage. Urology 42:409–411.
Wei, X. Q., Charles, I. G., Smith, A., Ure, J., Feng, G. J., Huang, F. P., Xu, D., Muller, W., Moncada, S., and Liew, F. Y, 1995, Altered immune responses in mice lacking inducible nitric oxide synthase, Nature 375:408–411.
Weller, R., Ormerod, A. D., Hobson, R. P., and Benjamin, N. J., 1998, A randomized trial of acidified nitrite cream in the treatment of tinea pedis, J. Am. Acad. Dermatol. 38:559–563.
Wright, C. E., Rees, D. D., and Moncada, S., 1992, Protective and pathological roles of nitric oxide in endotoxin shock, Cardiovasc. Res. 26:48–57.
Wu, C. C., Croxtall, J. D., Perretti, M., Bryant, C. E., Thiemermann, C., Flower, R. J., and Vane, J. R., 1995, Lipocortin 1 mediates the inhibition by dexamethasone of the induction by endotoxin of nitric oxide synthase in the rat, Proc. Natl. Acad. Sci. USA 92:3473–3477.
Xu, D. M., McSorley, S. J., Tetley, L., Chatfield, S., Dougan, G., Chan, W. L., Satoskar, A., David, J. R., and Liew, F. Y., 1998, Protective effect on Leishmania major infection of migration inhibitory factor, TNF-alpha, and IFN-gamma administered orally via attenuated Salmonella typhimurium, J. Immunol. 160:1285–1289.
Yamagushi, H. S., Abe, S., and Tokuda, Y, 1993, Immunomodulatory activity of antifungal drugs, Ann. N.Y. Acad. Sci. 685:447–457.
Zhou, P., Sieve, M. C., Tewari, R. P., and Seder, R. A., 1997, Interleukin-12 modulates the protective immune response in SCID mice infected with Histoplasma capsulatum, Infect. Immun. 65:936–942.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Vazquez-Torres, A., Fang, F.C. (2002). Therapeutic Applications of Nitric Oxide in Infection. In: Fang, F.C. (eds) Nitric Oxide and Infection. Springer, Boston, MA. https://doi.org/10.1007/0-306-46816-6_23
Download citation
DOI: https://doi.org/10.1007/0-306-46816-6_23
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46147-7
Online ISBN: 978-0-306-46816-2
eBook Packages: Springer Book Archive